Oncology ImagingArchives
Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics
Oncology Imaging 7 min.
PDAC, representing approximately 85% of pancreatic malignancies, ranks among the most lethal solid tumors with a 5-year survival rate below 10%. Surgical resection is the only curative treatment for this disease [1, 2, 3–4]. Although surgical resection remains the sole curative option, over 80%...
Low-Dose Computed Tomography Screening for Lung Cancer in Asia, Including Never-Smokers.
Oncology Imaging 1 min.
Lung cancer in never-smokers (LCINS) presents a distinct epidemiological profile in Asia, with a higher proportion of cases occurring in never-smoking women. This review examines the evidence for lung cancer screening in this population, synthesizing data on risk factors, LDCT screening, and current...
Clinical utility of ultrasound in the assessment of sarcopenia in cancer patients: A cross-sectional study.
Oncology Imaging 1 min.
Sarcopenia, defined as the loss of muscle mass accompanied by reduced strength and/or physical performance, is associated with numerous health risks, including falls, complications, prolonged hospitalization, and increased mortality. In cancer patients, sarcopenia is not only age-related but also aggravated...
Retrospective analysis of [99mTc]Tc-HYNIC-PSMA single photon emission computed tomography CT in patients with prostate cancer.
Oncology Imaging 1 min.
Prostate cancer is one of the most common malignancies in men. While multiparametric MRI is the gold standard for local staging of prostate cancer, accessibility may be limited. The same is true for Prostate Specific Membrane Antigen (PSMA) PET/computed tomography (CT). This study evaluates the diagnostic...
